Bio-Techne Corp (TECH)
Debt-to-equity ratio
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,918,810 | 2,068,850 | 1,966,520 | 1,701,010 | 1,571,230 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
June 30, 2025 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,918,810K
= 0.00
The debt-to-equity ratio for Bio-Techne Corp remains consistently at 0.00 across the fiscal years ending June 30, 2021, through June 30, 2025. This indicates that the company's total liabilities have been negligible or effectively zero relative to its shareholders' equity throughout this period. A persistent debt-to-equity ratio of zero suggests that Bio-Techne Corp has funded its operations primarily through wholly equity-based sources, with little to no reliance on external debt financing. Such a financial structure tends to equate to a conservative financing strategy, potentially reducing leverage-related financial risk. Overall, the company maintains a debt profile characterized by an absence of debt obligations, reflecting either a preference for equity financing or a position of strong liquidity and cash reserves sufficient to support its operational and strategic needs without incurring debt.
Peer comparison
Jun 30, 2025